Philip Morris International Acquires Fertin Pharma from EQT Private Equity

Philip Morris International to Acquire Vectura Group

July 9, 2021

Healthcare Services

Philip Morris International (PMI) announced it has agreed to an all-cash, recommended offer to acquire Vectura Group plc for an enterprise value of GBP 852 million (approximately USD 1.2 billion). The deal is expected to close in the second half of 2021, subject to shareholder and regulatory approvals.

Molex to Acquire Vectura Group From Philip Morris International (PMI)

September 17, 2024

Medical Devices

Vectura Group Ltd., a subsidiary of Philip Morris International (PMI) and part of Vectura Fertin Pharma, has signed an agreement to be sold to Molex Asia Holdings Ltd. The deal includes upfront cash consideration of GBP 150 million (subject to customary adjustments) plus potential deferred payments of up to GBP 148 million, with closing subject to regulatory approvals and other customary conditions.

Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Pharmaceuticals

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

Fulgent Genetics Acquires Fulgent Pharma

November 7, 2022

Biotechnology

Fulgent Genetics completed the acquisition of Fulgent Pharma Holdings for approximately $100 million in a combination of cash and Fulgent common stock. The deal integrates Fulgent Pharma’s nanoencapsulation drug-delivery platform and clinical-stage oncology pipeline with Fulgent Genetics’ diagnostics capabilities to create a vertically integrated precision-medicine offering focused on cancer.

MidOcean Partners Acquires QualiTech

June 7, 2023

Food & Beverage

MidOcean Partners, a New York-based private equity firm, has acquired QualiTech, a family-owned manufacturer of food ingredients, animal nutrition and plant nutrition products, from the Ploen family. The transaction will provide capital to expand QualiTech’s capabilities, capacity and product innovation as part of MidOcean’s food value chain investment strategy; terms were not disclosed.

Fremman Capital and Chequers Capital Enter Put Option to Acquire Bertin Technologies

December 2, 2025

Industrial Services

Fremman Capital and Chequers Capital have executed a put option agreement to acquire Bertin Technologies Group, a European advanced instrumentation provider, from its majority shareholder FCDE alongside management and BNP Paribas Développement. The deal is intended to help Bertin accelerate organic growth, improve operational performance, and expand capabilities and international reach, with co-control planned alongside management subject to approvals and consultation with employee representatives.